Did you mean cognitive changes and multiple sclerostin?
Overview
As many as 80 percent of people with multiple sclerosis (MS) choose to incorporate non-traditional therapies into their treatment plan. These treatments may be in addition to (complementary) or instead of… read more
Overview
Ocrevus Zunovo is approved by the U.S. Food and Drug Administration (FDA) for treating relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active…
Overview
Ampyra is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to improve walking speed in adults with all types of multiple sclerosis (MS). It is the first drug that has been… read more
Overview
Dalfampridine is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to improve walking speed in adults with relapsing multiple sclerosis (MS). It is the first drug approved for… read more